MARVERTI, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.972
EU - Europa 6.138
AS - Asia 4.864
SA - Sud America 727
AF - Africa 65
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 24.786
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.826
GB - Regno Unito 1.774
CN - Cina 1.698
SG - Singapore 1.590
IT - Italia 1.237
DE - Germania 732
SE - Svezia 684
BR - Brasile 597
HK - Hong Kong 553
RU - Federazione Russa 324
FR - Francia 306
VN - Vietnam 261
FI - Finlandia 232
PL - Polonia 213
UA - Ucraina 192
KR - Corea 160
TR - Turchia 131
IN - India 113
CA - Canada 97
ID - Indonesia 97
BG - Bulgaria 85
JP - Giappone 67
IE - Irlanda 62
AR - Argentina 58
BE - Belgio 55
LT - Lituania 55
NL - Olanda 48
ES - Italia 36
MX - Messico 36
BD - Bangladesh 34
ZA - Sudafrica 33
CZ - Repubblica Ceca 24
EC - Ecuador 23
IQ - Iraq 21
PK - Pakistan 17
CH - Svizzera 16
MY - Malesia 16
AE - Emirati Arabi Uniti 14
CO - Colombia 14
TW - Taiwan 13
AT - Austria 12
CL - Cile 12
AU - Australia 11
IR - Iran 9
RO - Romania 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
EG - Egitto 7
KE - Kenya 7
PY - Paraguay 7
UY - Uruguay 7
DK - Danimarca 6
GR - Grecia 6
KZ - Kazakistan 6
MA - Marocco 6
VE - Venezuela 6
JO - Giordania 5
NP - Nepal 5
PT - Portogallo 5
AZ - Azerbaigian 4
DZ - Algeria 4
EU - Europa 4
HU - Ungheria 4
IL - Israele 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PH - Filippine 4
BH - Bahrain 3
BY - Bielorussia 3
GE - Georgia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
PE - Perù 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
DO - Repubblica Dominicana 2
LB - Libano 2
MD - Moldavia 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
OM - Oman 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 24.777
Salva come PNG Salva come JPEG
Città #
Fairfield 1.252
Ashburn 1.222
Santa Clara 1.189
Southend 1.185
Singapore 902
Woodbridge 827
Chandler 796
Hefei 585
Hong Kong 543
Ann Arbor 540
Seattle 520
Houston 516
Cambridge 434
Wilmington 420
Nyköping 378
Jacksonville 376
Dearborn 358
Chicago 314
Los Angeles 292
Modena 290
London 262
Beijing 246
Frankfurt am Main 224
New York 215
Munich 179
Kraków 169
Helsinki 142
Seoul 141
Salt Lake City 123
San Diego 120
Princeton 89
Ho Chi Minh City 84
Jakarta 84
Sofia 84
The Dalles 81
Bologna 80
Moscow 80
Eugene 79
Fremont 77
Izmir 70
Shanghai 63
São Paulo 62
Tampa 62
Council Bluffs 59
Dublin 59
Dallas 54
Hanoi 54
Milan 54
Buffalo 53
Boardman 48
Elk Grove Village 47
Brussels 45
Parma 43
Redwood City 42
Tokyo 42
Phoenix 38
Warsaw 37
Orem 36
Lancaster 34
Des Moines 33
Guangzhou 31
Denver 30
Grafing 28
Miami 28
Ottawa 28
Sterling 28
Columbus 26
Stockholm 26
Atlanta 25
Bremen 25
Toronto 25
Norwalk 24
Montreal 22
Brooklyn 21
Reggio Emilia 21
San Jose 21
Chennai 20
Dulles 20
Falls Church 20
Kent 20
Turku 20
Brno 19
Dong Ket 19
San Mateo 19
Verona 19
Amsterdam 18
Nanjing 18
Rome 18
Washington 18
Brasília 17
Poplar 17
Belo Horizonte 16
Boston 16
Formigine 16
Augusta 15
Detroit 15
Ferrara 15
Jinan 15
Manchester 15
Mexico City 15
Totale 17.362
Salva come PNG Salva come JPEG
Nome #
Cisplatin-resistance modulates the effect of protein synthesis inhibitors on spermidine/spermine N-1-acetyltransferase expression 438
N-1,N-12-bis(ethyl)spermine effect on growth of cis-diamminedichloroplatinum(II)-sensitive and -resistant human ovarian-carcinoma cell lines 427
Spermidine/spermine N1-acetyltranferasemodulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistanthuman ovarian cancer cell lines 417
Spermidine/spermine N1-acetyltransferase transient over-expression restores sensitivity of resistant human ovarian cancer cells to N1,N12-bis(ethyl)spermine and to cisplatin 417
Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells. 413
Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells 413
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 408
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 404
Synthesis, cytotoxic and combined cDDP activity of new stable curcumin derivatives 385
Newly synthesized curcumin derivatives: crosstalk between chemico-physical properties and biological activity. 372
Internalization and stability of a thymidylate synthase peptide inhibitor in ovarian cancer cells 372
1H, 13C, 195Pt NMR study on platinum(II) interaction with sulphur containing Amadori compounds 361
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 360
Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth 357
Polyamine depletion switches the form of 2-deoxy-D-ribose-induced cell death from apoptosis to necrosis in HL-60 cells. 353
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 342
Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells 339
Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology 335
Repurposing of drugs targeting yap-tead functions 333
Mass Spectrometric/Bioinformatic Identification of a Protein Subset That Characterizes the Cellular Activity of Anticancer Peptides 333
The effect of spermine on calcium requirement for protein kinase C association with phospholipid vesicles. 329
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance 329
Synthesis, chemical and biological studies on new Fe3þ-glycosilated b-diketo complexes for the treatment of iron deficiency 326
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 317
Translational repression of thymidylate synthase by targeting its mRNA 315
Polyamine depletion protects HL-60 cells from 2-deoxy-D-ribose-induced apoptosis. 313
Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and-resistant human ovarian cancer cells 305
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells 304
Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells 302
Proteomic Approach to the Detection of the Mechanism of Action of Anticancer Peptides 299
Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies 297
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 292
Effect of Spermine on Membrane-Associated and Membrane-Inserted Forms of Protein Kinase C 289
Modulation of cis-diamminedichloroplatinum(II) accumulation and cytotoxicity by spermine in sensitive and resistant human ovarian carcinoma cells. 286
ANTICANCER DRUGS 285
Differential induction of spermidine/spermine N1-acetyltransferase activity in cisplatin-sensitive and -resistant ovarian cancer cells in response to N1,N12-bis (ethyl)spermine involves transcriptional and post-transcriptional regulation. 284
A proteomic approach to investigate the mechanism of action of anticancer peptides 281
PTEROATE-PEPTIDE BIOCONJUGATE TARGETING THE FOLATE RECEPTOR IN HUMAN OVARIAN CANCER CELL LINES: TRANSPORT AND MECHANISM OF ACTION. 278
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells 274
Spermine protects protein kinase C from phospholipid-induced inactivation 267
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting 266
2-Deoxy-D-ribose-induced apoptosis in HL-60 cells is associated with the cell cycle progression by spermidine 258
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 253
Depletion of Trichoplein (TpMs) Causes Chromosome Mis-Segregation, DNA Damage and Chromosome Instability in Cancer Cells 253
Heat shock protein 90 and serine/threonine kinase B-Raf inhibitors have overlapping chemical space 251
The 1,10-phenanthroline ligand enhances the antiproliferative activity of dna-intercalating thiourea-pd(Ii) and-pt(ii) complexes against cisplatin-sensitive and-resistant human ovarian cancer cell lines 251
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 248
Collateral sensitivity to novel folate cycle inhibitors enhances cisplatin effectiveness against human ovarian cancer cells. 246
Inhibitor of Ovarian Cancer Cells growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 246
Ligand-Based Virtual Screening and ADME-Tox Guided Approach to Identify Triazolo-quinoxalines as Folate Cycle Inhibitors. 246
N-(naphthyl)-N′-(methoxy carbonyl)thiocarbamide and its Cu(I) complex: synthesis, spectroscopic, X-ray, DFT andin vitrocytotoxicity study 242
Chairperson EUTROC- Mayo Conference-Berlin - Preliminary characterization of pharmacodynamic biomarkers for LR-peptide growth inhibition of ovarian cancer (OC) cell models. 242
Designing selective Cys-ligands to unpair the binding of the Human Transcription Enhancer Associated Domain 4 (hTEAD-4) with its modulators to halt cancer cell growth 241
Relationship Between Spermine and Calcium on the Activation Process of Protein Kinase C. 238
Invited lecture to 18th World Congress on Advances in Oncology and 16th International Symposium on Molecular Medicine 10-12 October, 2013, Creta Maris, Hersonissos, Crete, Greece 238
Transcriptional activation and cell cycle block are the keys for 5-fluorouracil induced up-regulation of human thymidylate synthase expression 234
Development of new metal-chelating multi target drus derived from Curcumin 230
Effect of spermine on association of protein kinase C with phospholipid vesicles. 226
Synthesis, molecular structure exploration and in vitro cytotoxicity screening of five novel N, N′- disubstituted thiocarbamide derivatives 224
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 219
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 216
Folate Receptor Expression and Folate Receptor Targeted Chemotherapy in Cisplatin-sensitive and – resistant Human cancer cell lines Marverti G.a, Pirondi S.a, MarracciniC.a, Frassineti C.a, Helleman J.b, Berns E.M.J.J. b, and Costi, M.P. cThe 4th International Symposium on Folate Receptors and Transporters Cozumel, Mexico October 7 - 11, 2012 212
Copper (I) complexes based on novel N, N'-disubstituted thiocarbamides: Synthesis, spectroscopic, in vitro cytotoxicity, DNA damage and G0/G1 cell cycle arrest studies 207
design, synthesis and biological evaluation of novel YAP:TEAD complex disruptors for thetreatment of colorectal cancer 201
Monodentate Coordination of N, N′-Disubstituted Thiocarbamide Ligands: Syntheses, Structural Analyses, In Vitro Cytotoxicity and DNA Damage Studies of Cu(I) Complexes 200
Exploring the biological activity of a library of 1,2,5-Oxadiazole derivatives endowed with antiproliferative activity 200
Glucosyl curcuminoid derivatives: Fe(III) and Ga(III) chelating agents with anti-cancer properties 197
Development of a novel class of YAP:TEAD interface-3 molecular disruptors to treat colorectal carcinoma 193
LC-MS serum proteomics reveals a panel of proteins prognostic of positive responsiveness to bevacizumab therapy in late-stages ovarian cancer patients 190
A toolbox of biophysical and analytical assays helps to confirm the activity of novel hTS dimer disrupters (Ddis) with anticancer properties 189
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 189
Erratum: Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 34 (E542-E549) DOI: 10.1073/pnas.1104829108) 186
Glucosyl curcuminoid derivatives: Fe(III) and Ga(III) chelating agents with anti-cancer properties 185
SSAT modulation by putative regulators of folate cycle enzymes expression in cisplatin-sensitive and –resistant human ovarian cancer cell lines. 184
Copper (I) complexes of N-(2/4 methoxy/2-chloro-4-nitro) phenyl-N’ (methoxycarbonyl) thiocarbamides as potential anticancer agents: Synthesis, crystal structure, in vitro cytotoxicity and DNA damage studies. 184
Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: an altered responce in accumulation-defective resistant cells. 181
Synthesis, characterization, Hirshfeld surface, cytotoxicity, DNA damage and cell cycle arrest studies of N, N-diphenyl-N'-(biphenyl-4- carbonyl/4-chlorobenzoyl) thiocarbamides 172
Differential induction of spermidine/spermine N1-acetyltransferase in cisplatin-sensitive and -resistant human breast cancer cells by N1, N12-bis(ethyl)spermine. 171
Structural bases for the synergistic inhibition of human thymidylate synthase and ovarian cancer cell growth by drug combinations 168
Experimental and theoretical exploration of molecular structure and anticancer properties of two N, N′–disubstituted thiocarbamide derivatives 167
Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library 167
Targeting the dimer-monomer equilibrium of thymidylate synthase, to accelerate protein degradation and cancer cell growth inhibition 163
Effect of spermine on irreversible insertion of protein kinase C into phospholipid vesicles. 162
Effetto delle poliammine sulla regolazione della proteina cinasi C. 159
Lead optimization of human thymidylate synthase dimer disrupters: from computational studies to evaluation of their biological profiles 157
Lead-optimization process and characterization of the dissociative effect applied to new dimer disrupters of human Thymidylate Synthase 153
Telomere Dysfunction Is Associated with Altered {DNA} Organization in Trichoplein/Tchp/Mitostatin ({TpMs}) Depleted Cells 153
Enhanced anticancer effect of thymidylate synthase dimer disrupters by promoting intracellular accumulation 148
Integrating MS proteomics in the Medicinal Chemistry pipeline as powerful tool to overcome drug resistance issues in colorectal cancer 147
Precision medicine through proteomics studies in drug resistant colorectal cancer 142
Inhibition of cell growth by accumulated spermine is associated with a transient alteration of cell cycle progression 142
Development of a sensitive biochemical tool to assess the expression levels of recombinant ectopic proteins in in vitro engineered cellular systems 141
Synthesis, spectroscopic, crystal structure and in vitro cytotoxicity studies of N-thiophenoyl-N'-substituted phenyl thiocarbamide derivatives 141
Cellular uptake and metabolic degradation of a conjugate of folic acid with an anticancer peptide targeting the human Thymidylate synthase enzyme 139
Dabrafenib-Panobinostat Salt: Improving Dissolution Rate and Inhibition of BRAF Melanoma Cells 115
Structural, Hirshfeld surface and in vitro cytotoxicity evaluation of five new N-aryl-N’-alkoxycarbonyl thiocarbamide derivatives. 113
MS Proteomics And Biochemical Characterization Of Thymidylate Synthase Dimer Destabilizer E7 To Halt Colorectal Carcinoma 106
Synthesis, characterisation, Hirshfeld surface and in vitro cytotoxicity evaluation of new N-aryl-N0-Alkoxycarbonyl thiocarbamide derivatives. 106
Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy 98
Structural insight into YAP-TEAD4 protein-protein interactions as target for cancer treatment 98
Totale 24.945
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.056
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.692 0 0 0 0 0 176 224 324 133 445 227 163
2021/20221.929 99 121 162 78 100 206 72 90 230 146 402 223
2022/20232.197 239 284 165 235 228 278 82 250 237 32 91 76
2023/20241.790 61 122 119 107 525 202 73 121 31 48 193 188
2024/20254.966 164 49 145 318 923 739 370 319 516 204 566 653
2025/20265.489 671 377 637 1.302 1.944 558 0 0 0 0 0 0
Totale 25.040